0001437749-19-022844.txt : 20191114 0001437749-19-022844.hdr.sgml : 20191114 20191114114605 ACCESSION NUMBER: 0001437749-19-022844 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191114 DATE AS OF CHANGE: 20191114 EFFECTIVENESS DATE: 20191114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Luminary Therapeutics, Inc. CENTRAL INDEX KEY: 0001793860 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-353363 FILM NUMBER: 191217963 BUSINESS ADDRESS: STREET 1: 1621 E. HENNEPIN AVENUE STREET 2: SUITE 290 CITY: MINNEAPOLIS STATE: MN ZIP: 55414 BUSINESS PHONE: 612-309-7653 MAIL ADDRESS: STREET 1: 1621 E. HENNEPIN AVENUE STREET 2: SUITE 290 CITY: MINNEAPOLIS STATE: MN ZIP: 55414 D 1 primary_doc.xml X0708 D LIVE 0001793860 Luminary Therapeutics, Inc. 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 612-309-7653 DELAWARE None None Corporation true 2019 Jeff Liter 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 Executive Officer Director Promoter David Largaespada 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 Executive Officer Director Promoter Biotechnology Decline to Disclose 06b false 2019-10-29 false true false 0 1490000 1490000 0 true 2 11 0 0 0 false Luminary Therapeutics, Inc. /s/ Jeff Liter Jeff Liter Chief Executive Officer 2019-11-13